Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MW031 in postmenopausal osteoporosis
NCT05215977Phase 3Completed
- Sponsor
- Mabwell
- Start
- Dec 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 9MW0311 in postmenopausal osteoporosis, sponsored by Mabwell. Started Dec 2019; status: completed.
02
Drugs
9MW0311
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT05215977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05215977.